Moderated Poster Sessions 1: Valvular heart disease: from bench to bedside * Thursday 8 December 2011, 08:30-12:30 * Location: Moderated Poster Area
M. Weber, Itaru Takamisawa(Sakakibara Hospital), Diana Momčilović(University Hospital Bonn), Georg Nickenig(University of Bonn), Laurent Macron(Clinique Hartmann), M. Sugawara, M. Cho, Christoph Hammerstingl, Romain Capoulade, Duk‐Hyun Kang(Ulsan College), K. K. Teo, Julien Nahum(Inserm), Thierry Le Tourneau, F. Kyndt, Pascal Guéret(Hôpitaux Universitaires Henri-Mondor), Marie‐Annick Clavel(University of Southern Denmark), Y.-G. Kim, Albert Hagège, Kuei‐Hui Chan, Kyoung Jin Hwang, D.-H. Kim, P. Pibarot, W. Lee, Robert Schueler, Nicolas Werner, Patrick Mathieu(Institut universitaire de cardiologie et de pneumologie de Québec), Bingxin Sun, Jean‐Luc Dubois Randé(Inserm), H. La Marec, A. Lardeux, Nancy Côté, Kiyomi Niki, Sung-Hwan Choi, Jaejoon Song, David Attias(Assistance Publique – Hôpitaux de Paris), A. Bensaid(Hôpitaux Universitaires Henri-Mondor), J. Schott, R. Levine, J L Monin, J. Després, Paul Lim, Jianlon Song, Alexander Ghanem(Asklepios Klinik St. Georg), J Tam(University of Colorado System), Jan‐Malte Sinning(University Hospital Bonn), Jean Mérot, J. Dumesnil, Vincent Probst(Centre National de la Recherche Scientifique)
Cited by 0
Related Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis
|Circulation|1999|671
Cryptogenic Stroke and High-Risk Patent Foramen Ovale
|Journal of the American College of Cardiology|2018|570
Acute Myocardial Infarction
|Circulation|2017|534